1. Energy failure in multiple sclerosis and its investigation using MR techniques

   • David Paling
   • Xavier Golay
   • David Miller

   Review 10 June 2011 Pages: 2113 - 2127

   

2. Requirements for generic antiepileptic medicines: a clinical perspective

   • Eugen Trinka
   • Günter Krämer
   • Martin Graf

   Review 11 June 2011 Pages: 2128 - 2132

3. Secondary infarction in single or in multiple vascular territories: two different entities following subarachnoid hemorrhage?

   • N. K. de Rooij
   • C. J. M. Frijns
   • G. J. E. Rinkel

   Original Communication Open access 07 May 2011 Pages: 2133 - 2139

   

4. Three cases of CLIPPERS: a serial clinical, laboratory and MRI follow-up study

   • O. Kastrup
   • J. van de Nes
   • K. Keyvani

   Original Communication 10 May 2011 Pages: 2140 - 2146

   

5. The role of ¹²³I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases

   • Friederike Sixel-Döring
   • Knut Liepe
   • Claudia Trenkwalder

   Original Communication 06 May 2011 Pages: 2147 - 2154

6. Neuropsychiatric symptoms and intelligence quotient in autosomal dominant Segawa disease

   • Eduardo López-Laso
   • Araceli Sánchez-Raya
   • Rafael Artuch

   Original Communication 10 May 2011 Pages: 2155 - 2162

   

7. Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients

   • Ken Sakushima
   • Ichiro Yabe
   • Hidenao Sasaki

   Original Communication 07 May 2011 Pages: 2163 - 2167

   

8. Neural substrates of good and poor recovery after hemiplegic stroke: a serial pet study

   • G. Nelles
   • W. Jentzen
   • H. C. Diener

   Original Communication 24 May 2011 Pages: 2168 - 2175

   

9. Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica

   • Sung-Min Kim
   • Patrick Waters
   • Kwang-Woo Lee

   Original Communication 19 May 2011 Pages: 2176 - 2180

   

10. Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer’s disease

    • Jihye Choi
    • Ho-Won Lee
    • Kyoungho Suk

    Original Communication 12 May 2011 Pages: 2181 - 2185

11. Altered patterns of cortical activation in ALS patients during attention and cognitive response inhibition tasks

    • L. H. Goldstein
    • I. C. Newsom-Davis
    • A. Simmons

    Original Communication Open access 10 May 2011 Pages: 2186 - 2198

    

12. Fatigue and progression of corpus callosum atrophy in multiple sclerosis

    • Özgür Yaldizli
    • Stephanie Glassl
    • Norman Putzki

    Original Communication 19 May 2011 Pages: 2199 - 2205

    

13. Acute transverse myelitis in demyelinating diseases among the Chinese

    • R. Li
    • W. Qiu
    • X. Hu

    Original Communication 18 May 2011 Pages: 2206 - 2213

    

14. Physical inactivity in Parkinson’s disease

    • Marlies van Nimwegen
    • Arlène D. Speelman
    • Marten Munneke

    Original Communication Open access 26 May 2011 Pages: 2214 - 2221

    

15. The impact of sleep and mood disorders on quality of life in Parkinson’s disease patients

    • Eva Havlikova
    • Jitse P. van Dijk
    • Johan W. Groothoff

    Original Communication 26 May 2011 Pages: 2222 - 2229

16. Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington’s disease provides in vivo evidence for impaired energy metabolism

    • Simon J. A. van den Bogaard
    • Eve M. Dumas
    • Jeroen van der Grond

    Original Communication Open access 26 May 2011 Pages: 2230 - 2239

    

17. Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI

    • Maria Laura Stromillo
    • Alessandro Malandrini
    • Nicola De Stefano

    Original Communication 29 May 2011 Pages: 2240 - 2247

    

18. Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C)

    • Esteban Muñoz
    • Alex Iranzo
    • Eduardo Tolosa

    Original Communication 03 June 2011 Pages: 2248 - 2253

    

19. Sleep disturbances in untreated Parkinson’s disease

    • Jitka Bušková
    • Jiří Klempíř
    • Evžen Růžička

    Original Communication 03 June 2011 Pages: 2254 - 2259

    

20. Phenotype analysis in patients with early onset Parkinson’s disease with and without parkin mutations

    • Hee Jin Kim
    • Han-Joon Kim
    • Beom S. Jeon

    Original Communication 29 May 2011 Pages: 2260 - 2267

21. A case of glycine-receptor antibody-associated encephalomyelitis with rigidity and myoclonus (PERM): clinical course, treatment and CSF findings

    • A. Piotrowicz
    • A. Thümen
    • A. Moser

    Letter to the Editors 04 May 2011 Pages: 2268 - 2270

    

22. Bilateral abducens nerve palsy by compression from bilateral anterior inferior cerebellar artery

    • Akira Taniguchi
    • Yuichiro Ii
    • Hidekazu Tomimoto

    Letter to the Editors 08 May 2011 Pages: 2271 - 2273

    

23. Intravenous amantadine is safe and effective for the perioperative management of patients with Parkinson’s disease

    • Young Eun Kim
    • Han-Joon Kim
    • Beom S. Jeon

    Letter to the Editors 06 May 2011 Pages: 2274 - 2275

24. Vagus nerve somatosensory evoked potentials in Parkinson’s disease

    • T. Polak
    • D. Weise
    • J. Classen

    Letter to the Editors 11 May 2011 Pages: 2276 - 2277

25. Dissection of the posterior inferior cerebellar artery in the hypereosinophilic syndrome

    • J. van Gaalen
    • E. J. van Dijk
    • F.-E. de Leeuw

    Letter to the Editors Open access 12 May 2011 Pages: 2278 - 2280

    

26. Rituximab in c-ANCA associated vasculitic polyneuropathy complicated by local peritonitis

    • Jens Witsch
    • Werner Stenzel
    • George Trendelenburg

    Letter to the Editors 15 May 2011 Pages: 2281 - 2283

    

27. BAFF serum levels in myasthenia gravis: effects of therapy

    • Flavia Scuderi
    • Paolo E. Alboini
    • Amelia Evoli

    Letter to the Editors 11 May 2011 Pages: 2284 - 2285

    

28. Adult onset Pompe disease associated with multiple sclerosis

    • Maria Sepulveda
    • Elvira Munteis
    • Jaume Roquer

    Letter to the Editors 26 May 2011 Pages: 2286 - 2287

    

29. Brainstem congestion due to carotid-cavernous fistula via a shunt from the external carotid artery

    • Yoko Ito
    • Nobuo Sanjo
    • Hidehiro Mizusawa

    Letter to the Editors 24 May 2011 Pages: 2288 - 2290

    

30. Seizure, syncope, or both: cardiac pacemaker reveals temporal lobe epilepsy

    • Jan Rémi
    • Soheyl Noachtar

    Letter to the Editors 27 May 2011 Pages: 2291 - 2292

    

31. Anhidrosis associated with hypothalamic lesions related to anti-aquaporin 4 autoantibody

    • Teruhiko Sekiguchi
    • Satoru Ishibashi
    • Hidehiro Mizusawa

    Letter to the Editors 03 June 2011 Pages: 2293 - 2295

    

32. Levodopa-induced breathing, cognitive and behavioral changes in Parkinson’s disease

    • Nicola Tambasco
    • Vincenzo Belcastro
    • Aroldo Rossi

    Letter to the Editors 08 June 2011 Pages: 2296 - 2299

    

33. Mykhailo Mykytovych Lapinsky (1862–1947)

    • S. M. Vinychuk

    Pioneers in Neurology 28 June 2011 Pages: 2300 - 2301

    

34. Multiple sclerosis: iron mapping, predicting response to interferon-β and effects of oral teriflunomide

    • M. Strupp

    Journal Club 26 November 2011 Pages: 2302 - 2304

35. Recent advances in the diagnosis and treatment of balance disorders

    • Klaus Jahn
    • Marianne Dieterich

    Medical Progress in the Journal of Neurology 27 October 2011 Pages: 2305 - 2308

36. Communications of the European Neurological Society

    • Clay E. Reilly

    ENS COMMUNICATIONS 26 November 2011 Pages: 2309 - 2312